Testimonies submitted for the Institute of Medicine report. Epilepsy across the spectrum: Promoting health and understanding

Epilepsy and Behavior

Volumn 25, Issue 4, 2012, Pages 634-661

  Austin, Joan K ^a   Hesdorffer, Dale C ^b   Liverman, Catharyn T ^c   Schultz, Andrea M ^c  

^a INDIANA UNIVERSITY   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Institute of Medicine   (United States)

Author keywords

Epilepsy; Family; Health care; Institute of Medicine; Personal perceptions; Quality of life; Research; SUDEP

Indexed keywords

EPILEPSY; FAMILY; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HUMAN; MAJOR DEPRESSION; MEDICAL SOCIETY; PATIENT CARE; PERCEPTION; PSYCHOSOCIAL CARE; PUBLICATION; RESEARCH; REVIEW; SOCIAL ISOLATION; SOCIAL SUPPORT; WITNESS;

ADOLESCENT; ADULT; CHILD; COST OF ILLNESS; EPILEPSY; FAMILY; FEMALE; HUMANS; INSTITUTE OF MEDICINE (U.S.); MALE; MIDDLE AGED; QUALITY OF LIFE; SEIZURES; UNITED STATES; YOUNG ADULT;

EID: 84871719316     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.10.003     Document Type: Review

References (12)

1. IOM Epilepsy across the spectrum: promoting health and understanding 2012, The National Academies Press, Washington, DC.
2. England M.J., Liverman C.T., Schultz A.M., Strawbridge L.M. Epilepsy across the spectrum: Promoting health and understanding. A summary of the Institute of Medicine Report. Epilepsy Behav 2012, 25:266-276.
3. Ficker D.M., So E.L., Shen W.K., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 1998, 51(5):1270-1274.
4. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012, 53(2):227-233.
5. Nouri S. Sudden unexpected death in epilepsy [cited 2012 September 21]; Available from: http://emedicine.medscape.com/article/1187111-overview.
6. Skluzacek J.V., Watts K.P., Parsy O., Wical B., Camfield P. Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia 2011, 52:95-101.
7. Meisler M.H., Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders. JCL 2005, 115(8):2010-2017.
8. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51(6):1069-1077.
9. Hauser W.A., Kurland L.T. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975, 16(1):1-66.
10. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993, 34(3):453-468.
11. Kobau R., Zahran H., Thurman D.J., et al. Epilepsy surveillance among adults-19 states, Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill Summ 2008, 57(6):1-20.
12. Tomson T., Beghi E., Sundqvist A., Johannessen S.I. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 2004, 60(1):1-16.